Desmoplastic and spindle cell melanomas express protein markers of the neural crest but not of later committed stages of Schwann cell differentiation

Journal of Cutaneous Pathology

Volumn 29, Issue 9, 2002, Pages 562-568

  Huttenbach, Yve ^a   Prieto, Victor G ^b   Reed, Jon A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE CELL ADHESION MOLECULE; NERVE GROWTH FACTOR RECEPTOR; NEUROMODULIN; PERIPHERIN;

ARTICLE; CANCER STAGING; CELL DIFFERENTIATION; CELL LINEAGE; CELL TYPE; CLINICAL ARTICLE; DESMOPLASTIC MELANOMA; EARLY DIAGNOSIS; EPITHELIOID CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; MELANOMA; MYELINATION; NEURAL CREST; NEUROTROPISM; PROTEIN EXPRESSION; RECEPTOR AFFINITY; SCHWANN CELL; SPINDLE CELL MELANOMA;

CELL TRANSFORMATION, NEOPLASTIC; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MELANOMA; NEOPLASM PROTEINS; NEURAL CREST; RECEPTOR, NERVE GROWTH FACTOR; SCHWANN CELLS; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036797956     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0560.2002.290909.x     Document Type: Article

References (55)

1. Quinn MJ, Crotty KA, Thompson JF et al. Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients. Cancer 1998; 83: 1128.
2. Anstey A, Cerio R, Ramnarain N et al. Desmoplastic malignant melanoma. An immunocytochemical study of 25 cases. Am J Dermatopathol 1994; 16: 14.
3. Warner TF, Lloyd RV, Hafez GR, Angevine JM. Immunocytochemistry of neurotropic melanoma. Cancer 1984; 53: 254.
4. Orchard GE. Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB 45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma. Histochem J 2000; 32: 475.
5. Orosz Z. Melan-A/Mart-1 expression in various melanocytic lesions and in non-melanocytic soft tissue tumours. Histopathology 1999; 34: 517.
6. Skelton HG 3rd, Smith KJ, Barrett TL, Lupton GP, Graham JH. HMB-45 staining in benign and malignant melanocytic lesions. A reflection of cellular activation. Am J Dermatopathol 1991; 13: 543.
7. DiMaio SM, Mackay B, Smith JL Jr, Dickersin GR. Neurosarcomatous transformation in malignant melanoma: an ultrastructural study. Cancer 1982; 50: 2345.
8. Warner TF, Hafez GR, Finch RE, Brandenberg JH. Schwann cell features in neurotropic melanoma. J Cutan Pathol 1981; 8: 177.
9. Kanik AB, Yaar M, Bhawan J. p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma. J Cutan Pathol 1996; 23: 205.
10. Iwamoto S, Odland PB, Piepkorn M, Bothwell M. Evidence that the p75 neurotrophin receptor mediates perineural spread of desmoplastic melanoma. J Am Acad Dermatol 1996; 35: 725.
11. Iwamoto S, Burrows RC, Agoff SN et al. The p75 neurotrophin receptor, relative to other Schwann cell and melanoma markers, is abundantly expressed in spindled melanomas. Am J Dermatopathol 2001; 23: 288.
12. Trejo O, Reed JA, Prieto VG. Atypical cells in human cutaneous re-excision scars for melanoma express neurotrophins p75NGFR, CD56/N-CAM, and GAP-43: evidence of early Schwann cell differentiation. J Cutan Pathol 2002; 29: 397.
13. Zorick TS, Lemke G. Schwann cell differentiation. Curr Opin Cell Biol 1996; 8: 870.
14. Jessen KR, Mirsky R, Morgan L. Myelinated, but not unmyelinated axons, reversibly down-regulate N-CAM in Schwann cells. J Neurocytol 1987; 16: 681.
15. Mirsky R, Jessen KR. Schwann cell development, differentiation and myelination. Curr Opin Neurobiol 1996; 6: 89.
16. Le Douarin NM, Ziller C. Plasticity in neural crest cell differentiation. Curr Opin Cell Biol 1993; 5: 1036.
17. Van Paesschen MA, Goovaerts G, Buyssens N. A study of the so-called neurotization of nevi. Am J Dermatopathol 1990; 12: 242.
18. Schaumburg-Lever G, Lever I, Fehrenbacher B et al. Melanocytes in nevi and melanomas synthesize basement membrane and basement membrane-like material. An immunohisto-chemical and electron microscopic study including immuno-electron microscopy. J Cutan Pathol 2000; 27: 67.
19. Havenith MG, van Zandvoort EH, Cleutjens JP, Bosman FT. Basement membrane deposition in benign and malignant naevo-melanocytic lesions, an immunohistochemical study with antibodies to type IV collagen and laminin. Histopathology 1989; 15: 137.
20. Aso M, Hashimoto K, Eto H et al. Expression of Schwann cell characteristics in pigmented nevus. Immunohistochemical study using monodonal antibody to Schwann cell associated antigen. Cancer 1988; 62: 938.
21. Penneys NS, Mogollon R, Kowalczyk A, Nadji M, Adachi K. A survey of cutaneous neural lesions for the presence of myelin basic protein. An immunohistochemical study. Arch Dermatol 1984; 120: 210.
22. Gray MH, Smoller BR, McNutt NS, Hsu A. Neurofibromas and neurotized melanocytic nevi are immunohistochemically distinct neoplasms. Am J Dermatopathol 1990; 12: 234.
23. Reed JA, Finnerty B, Albino AP. Divergent cellular differentiation pathways during the invasive stage of cutaneous malignant melanoma progression. Am J Pathol 1999; 155: 549.
24. Prieto VG, McNutt NS, Lugo J, Reed JA. The intermediate filament peripherin is expressed in cutaneous melanocytic lesions. J Cutan Pathol 1997; 24: 145.
25. Lammerding-Koppel M, Noda S, Blum A et al. Immunohistochemical localization of muscarinic acetylcholine receptors in primary and metastatic malignant melanomas. J Cutan Pathol 1997; 24: 137.
26. Kohn EC, Alessandro R, Probst J et al. Identification and molecular characterization of a m5 muscarinic receptor in A2058 human melanoma cells. Coupling to inhibition of adenylyl cyclase and stimulation of phospholipase A2. J Biol Chem 1996; 271: 17476.
27. Khare VK, Albino AP, Reed JA. The neuropeptide/mast cell secretagogue substance P is expressed in cutaneous melanocytic lesions. J Cutan Pathol 1998; 25: 2.
28. Reed JA, Manahan LJ, Park CS, Brigati DJ. Complete one-hour immunocytochemistry based on capillary action. Biotechniques 1992; 13: 434.
29. Ross AH, Grob P, Bothwell M et al. Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies. Proc Natl Acad Sci USA 1984; 81: 6681.
30. Schol DJ, Mooi WJ, van der Gugten AA, Wagenaar SS, Hilgers J. Monoclonal antibody 123C3, identifying small cell carcinoma phenotype in lung tumours, recognizes mainly, but not exclusively, endocrine and neuron-supporting normal tissues. Int J Cancer Suppl 1988; 2: 34.
31. Meiri KF, Bickerstaff LE, Schwob JE. Monodonal antibodies show that kinase C phosphorylation of GAP-43 during axonogenesis is both spatially and temporally restricted in vivo. J Cell Biol 1991; 112: 991.
32. Kanitakis J, Bourchany D, Faure M, Claudy A. Expression of the intermediate filament peripherin in skin tumors. Eur J Dermatol 1998; 8: 339.
33. Gorham JD, Baker H, Kegler D, Ziff EB. The expression of the neuronal intermediate filament protein peripherin in the rat embryo. Brain Res Dev Brain Res 1990; 57: 235.
34. Kapfhammer JP, Schwab ME. Inverse patterns of myelination and GAP-43 expression in the adult CNS: neurite growth inhibitors as regulators of neuronal plasticity? J Comp Neurol 1994; 340: 194.
35. Christiansen JH, Coles EG, Wilkinson DG. Molecular control of neural crest formation, migration and differentiation. Curr Opin Cell Biol 2000; 12: 719.
36. Portier MM, Croizat B, Gros F. A sequence of changes in cytoskeletal components during neuroblastoma differentiation. FEBS Lett 1982; 146: 283.
37. Portier MM, de Nechaud B, Gros F. Peripherin, a new member of the intermediate filament protein family. Dev Neurosci 1983; 6: 335.
38. Moncla A, Landon F, Mattei MG, Portier M2M. Chromosomal localisation of the mouse and human peripherin genes. Genet Res 1992; 59: 125.
39. Blumenfeld A, Lucente DE, Trofatter JA et al. Peripherin gene is linked to keratin 18 gene on human chromosome 12. Somat Cell Mol Genet 1995; 21: 83.
40. Wong J, Oblinger MM. Differential regulation of peripherin and neurofilament gene expression in regenerating rat DRG neurons. J Neurosci Res 1990; 27: 332.
41. Escurat M, Djabali K, Gumpet M, Gros F, Portier MM. Differential expression of two neuronal intermediate-filament proteins, peripherin and the low-molecular-mass neurofilament protein (NF-L), during the development of the rat. J Neurosci 1990; 10: 764.
42. Rettig WJ, Thomson TM, Spengler BA, Biedler JL, Old LJ. Assignment of human nerve growth factor receptor gene to chromosome 17 and regulation of receptor expression in somatic cell hybrids. Somat Cell Mol Genet 1986; 12: 441.
43. Thompson SJ, Schatteman GC, Gown AM, Bothwell M. A monoclonal antibody against nerve growth factor receptor. Immunohistochemical analysis of normal and neoplastic human tissue. Am J Clin Pathol 1989; 92: 415.
44. Thomson TM, Rettig WJ, Chesa PG et al. Expression of human nerve growth factor receptor on cells derived from all three germ layers. Exp Cell Res 1988; 174: 533.
45. Argenyi ZB, Rodgers J, Wick M. Expression of nerve growth factor and epidermal growth factor receptors in neural nevi with nevic corpuscles. Am J Dermatopathol 1996; 18: 460.
46. Peacocke M, Yaar M, Mansur CP, Chao MV, Gilchrest BA. Induction of nerve growth factor receptors on cultured human melanocytes. Proc Natl Acad Sci USA 1988; 85: 5282.
47. Rettig WJ, Spengler BA, Chesa PG, Old LJ, Biedler JL. Coordinate changes in neuronal phenotype and surface antigen expression in human neuroblastoma cell variants. Cancer Res 1987; 47: 1383.
48. Cunningham BA, Hemperly JJ, Murray BA et al. Neural cell adhesion molecule: structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing. Science 1987; 236: 799.
49. Crossin KL, Chuong CM, Edelman GM. Expression sequences of cell adhesion molecules. Proc Natl Acad Sci USA 1985; 82: 6942.
50. Miettinen M, Cupo W. Neural cell adhesion molecule distribution in soft tissue tumors. Hum Pathol 1993; 24: 62.
51. Mechtersheimer G, Staudter M, Moller P. Expression of the natural killer cell-associated antigens CD56 and CD57 in human neural and striated muscle cells and in their tumors. Cancer Res 1991; 51: 1300.
52. Kosik KS, Orecchio LD, Bruns GA et al. Human GAP-43: its deduced amino acid sequence and chromosomal localization in mouse and human. Neuron 1988; 1: 127.
53. Scherer SS, Xu YT, Roling D et al. Expression of growth-associated protein-43 kD in Schwann cells is regulated by axon-Schwann cell interactions and cAMP. J Neurosci Res 1994; 38: 575.
54. Curtis R, Stewart HJ, Hall SM et al. GAP-43 is expressed by nonmyelin-forming Schwann cells of the peripheral nervous system. J Cell Biol 1992; 116: 1455.
55. He Q Dent EW, Meiri KF. Modulation of actin filament behavior by GAP-43 (neuromodulin) is dependent on the phosphorylation status of serine 41, the protein kinase C site. J Neurosci 1997; 17: 3515.